Press Releases

New Report Underscores Urgent Need for Investments in Alzheimer’s Research, Health Literacy and Clinical Trials for U.S. Latinos

LOS ANGELES, September 21, 2016—Unless a medical breakthrough is discovered that prevents, cures or slows the progression of Alzheimer’s disease, the incidence and cost of Alzheimer’s on U.S. Latinos will grow exponentially by 2060, according to a report released today by the USC Edward R. Roybal Institute on Aging at the USC Suzanne Dworak-Peck School of Social Work and LatinosAgainstAlzheimer’s, a network of UsAgainstAlzheimer’s.

WASHINGTON, DC, August 29, 2016—Following the passing of an artist who brought smiles and laughter to millions of all ages, UsAgainstAlzheimer’s recognizes the life and accomplishments of Gene Wilder, extends its condolences to his family and notes that this is another reminder of the urgent need to defeat a disease that continues to rob households, communities and our society of too many treasured individuals.

WASHINGTON, DC, August 4, 2016—The Centers for Medicare & Medicaid Services (CMS) decision not to reimburse everyday Americans for using what the FDA determined to be an effective diagnostic tool was found to be “arbitrary and capricious” by a Federal court. The reason? Because Medicare is reimbursing for a less effective diagnostic tool and did not explain why it would not do so for a more innovative tool.

TORONTO, July 26, 2016—The Global Alliance on Women’s Brain Health today hosted an issue roundtable and the launch of Phase II of the Health e-Brain Study, investigating the impact the caregiving experience has on brain and behavioral health at the Alzheimer's Association International Conference in Toronto.

TORONTO, July 22, 2016—As the Alzheimer’s Association International Conference (AAIC) kicks off, UsAgainstAlzheimer’s (UsA2)  will be an active participant across a number of fronts, spanning research, clinical trial recruitment, minimizing disparities and improving caregiver support, adding its voice among international investigators, clinicians and care providers to advance science and see critical dementia breakthroughs come to fruition.


^ Back to Top